Page 64 - Malaysian Journal of Health Promotion, Vol 4 (Supplementary 1) 2022

Malaysian Journal of Health Promotion, Vol 4 (Supplementary 1) 2022
rd
14 MOH-AMM Scientific Meeting 2022 in conjunction with 23 NIH Scientific Conference Abstract Book
th
hazard model was utilised to identify potential significant factors. All analysis were performed
using STATA v17.0.
RESULTS: Sixty-two MM patients were included in this study. The mean age was 62.95 (SD
1.35), ranging from 40-87 years old. The overall median survival time was 16 months. The
median survival times for males and females were 16 and 18 months, respectively. The Cox
proportional hazard model showed that the risk of dying was 0.21 times lower for patients
who took lenalidomide (p=0.013, 95% CI: 0.059-0.717). No significant difference was
observed in other factor variables analysed (p>0.05).
DISCUSSION/CONCLUSION: The survival distributions of MM patients in Sarawak between
2016-2020 were the same across sexes, age groups, ethnicities, and BMI groups. A larger
sample size is needed to give more reliable results with greater precision and power.

ID 41 PERSONAL PROTECTIVE EQUIPMENT (PPE) USE DURING COVID-19: ASSESSING THE
ATTITUDES OF HEALTHCARE WORKERS (HCWS)
1
1
1
1
Divya Nair Narayanan , Khalidah Maruan , Samsiah Awang , Nurhayati Shaharuddin , Izzatur Rahmi Mohd
1
1
2
Ujang , Normaizira Hamidi , Roslina Supadi , Mariyah Mohamad , Noraini Mohd Yusof , Shantini Thevendran ,
3
1
1
Muslisah Musa 3
1 Centre for Healthcare Quality Research, Institute for Health Systems Research, National Institutes of Health,
Ministry of Health Malaysia
2 Family Health Development Division, Ministry of Health Malaysia
3 Public Health Development Division, Ministry of Health Malaysia

INTRODUCTION: Multiple myeloma (MM) is the second most common haematologic
malignancy in the world and the third in Malaysia. The median survival of MM patients in the
United States who received modern therapy is approximately six years. However, in Malaysia,
the survival rate of MM patients is still unclear. Therefore, a single-centre study of MM
patients in Sarawak was done retrospectively to determine the survival outcomes and the
potential association between covariates and the survival time.
METHODS: A cross sectional study were conducted retrospectively among MM patients. Data
were retrieved from clinical notes of MM cases from the year 2016-2020 from the Sarawak
General Hospital. Kaplan–Meier was used to estimate the survival function of MM patients
and to calculate the survival rate from 1- to 60-month survival statistics. Cox proportional
hazard model was utilised to identify potential significant factors. All analysis were performed
using STATA v17.0.
RESULTS: Sixty-two MM patients were included in this study. The mean age was 62.95 (SD
1.35), ranging from 40-87 years old. The overall median survival time was 16 months. The
median survival times for males and females were 16 and 18 months, respectively. The Cox
proportional hazard model showed that the risk of dying was 0.21 times lower for patients
who took lenalidomide (p=0.013, 95% CI: 0.059-0.717). No significant difference was
observed in other factor variables analysed (p>0.05).
DISCUSSION/CONCLUSION: The survival distributions of MM patients in Sarawak between
2016-2020 were the same across sexes, age groups, ethnicities, and BMI groups. A larger
sample size is needed to give more reliable results with greater precision and power.

ID 42 ASSOCIATION OF INTERSTATE COVID-19 CLUSTER FORMATION WITH ORIGIN OF
CLUSTER AND TRAVEL RESTRICTIONS

1
1
1
1
2
1
Zen Yang Ang , Anis Syakira Jailani , Kit Yee Cheah , Yuke-Lin Kong , Nur Zahirah Balqis-Ali , Weng Hong Fun ,
1
1
Lee Ching Wann , Sondi Sararaks
38